Lifecore Biomedical, Inc. De (LFCR) Divestments (2021 - 2023)

Lifecore Biomedical has reported Divestments for 3 years, with the latest figure at $16.7 million in Q2 2023.

• On a quarterly basis, Divestments fell 41.3% year-over-year to $16.7 million in Q2 2023; TTM through Feb 2024 was $16.7 million, a 41.3% decrease from a year earlier, with the FY2023 full-year figure at $16.7 million, down 77.32% from the prior year.
• Divestments was $16.7 million for Q2 2023 at Lifecore Biomedical, up from -$3.1 million in the prior quarter.
• The five-year high for Divestments was $45.1 million in Q3 2021, with the low at -$3.1 million in Q1 2023.
• Average Divestments over 3 years is $18.0 million, with a median of $16.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Divestments plunged 93.05% in 2022, then slumped 41.3% in 2023.
• Over 3 years, Divestments stood at $45.1 million in 2021, then slumped by 93.05% to $3.1 million in 2022, then soared by 431.77% to $16.7 million in 2023.
• The last three Divestments figures came in at $16.7 million (Q2 2023), -$3.1 million (Q1 2023), and $3.1 million (Q3 2022), per Business Quant data.